Madrigal registers Phase 4 safety study of Rezdiffra with diabetes drugs in MASH patientsSep 29Trial updateMadrigal Pharmaceuticals, Inc.resmetirom
Olaparib Phase 2 results posted; three diabetes labels updated; new myeloma CAR-T trial recruitsAug 14Weekly roundup, 9 itemsAstraZenecaAZD0120
Sign inSign in